Tradestie Institutional Equity Comparison Engine

TENX vs PRTO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

TENX Overall Edge

TENX Captures Institutional Edge (2โ€“2 Pillars ยท 8โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Tenax Therapeutics, Inc. (TENX) driven by superior Valuation, Growth & Margin while PRTO counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, TENX trades at 0.3x Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus PRTO at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, TENX sits in BREAKDOWN (24th %ile IV; Dealer Gamma Walls on Pro) against PRTO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner TENX
TENX 0.3x vs PRTO N/M Fwd P/E
Growth & Margin Winner TENX
Op Margin 0.0% vs N/A ยท YoY +0.0% vs N/A
Momentum & Technical Winner PRTO
1Y -82.9% vs -3.4% ยท 52W Pos 0% vs 0%
Options & Structure Winner PRTO
BREAKDOWN (24th %ile IV) vs UNCLASSIFIED (N/A IV)
TENX NASDAQ
Tenax Therapeutics, Inc.
Pharmaceutical Preparations
$1.25
-10.07% 1D
Market Cap $63.3M
1M Return -28.98%
1Y Return -82.92%
Forward P/E 0.3x
Unified AI Score
45.5 / 100 HOLD
Tech 33.0 Fund 57.0 Flow 66.0 Mom 60.0
PRTO US Equity
PRTO
Institutional Equity
$24.45
-3.36% 1D
Market Cap N/A
1M Return -9.56%
1Y Return -3.39%
Forward P/E N/M
Unified AI Score
33.3 / 100 SELL
Tech 12.0 Fund 36.0 Flow 50.0 Mom 34.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: TENX -82.92% PRTO -3.39% Spread: +87.68 pp (PRTO Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
TENX TTM Op. Margin: 0.0% PRTO TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on TENX vs PRTO. Trailing 12-month operating profitability (TENX 0.0% vs PRTO N/A) and valuation multiples (TENX 0.3x vs PRTO N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: TENX (8) vs PRTO (1)
Institutional Metric TENX PRTO Criterion Row Winner
Market Capitalization Scale $63.3M N/A Larger Scale TENX
Trailing P/E Ratio Valuation 0.3x N/M Lower Multiple TENX
Forward P/E Ratio Valuation 0.3x N/M Lower Multiple TENX
Revenue Growth (YoY) Growth +0.0% N/A Higher Growth TENX
Operating Margin (TTM) Profitability 0.0% N/A Higher Margin TENX
Net Profit Margin Profitability 0.0% N/A Higher Margin TENX
Return on Equity (ROE) Capital Efficiency -64.2% N/A Higher ROE TENX
52-Week Range Position Momentum 0% ($1โ€“$19) 0% ($24โ€“$29) Stronger Trend Tie
Beta / 30D Volatility Risk Regime 1.42ฮฒ ยท 75% Vol 0.89ฮฒ ยท 21% Vol Lower Realized Risk PRTO
Unified Institutional Score Composite Signal 45.5 / 100 (HOLD) 33.3 / 100 (SELL) Higher Composite TENX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full TENX vs PRTO Buy Guide
TENX BREAKDOWN
95d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 24th %ile
IV Regime Compressed (<25th %ile)
Live TENX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PRTO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PRTO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither TENX nor PRTO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.